YTHDF1 and cancer: Furthermore, YTHDF1 knockdown inhibited cisplatin-resistant ovarian cancer cells with CSC-like characteristics (Hao et al., 2021), suggesting that YTHDF1 is a promising cancer marker to trace the recurrence of ovarian cancer.